These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18336699)
21. Impact of change in the United Kingdom pediatric donor organ allocation policy for intestinal transplantation. Giovanelli M; Gupte GL; McKiernan P; Pocock P; Beath SV; Lloyd C; Sharif K; Mayer DA; Mirza DF Transplantation; 2009 Jun; 87(11):1695-9. PubMed ID: 19502962 [TBL] [Abstract][Full Text] [Related]
22. OPTN/SRTR 2021 Annual Data Report: Liver. Kwong AJ; Ebel NH; Kim WR; Lake JR; Smith JM; Schladt DP; Schnellinger EM; Handarova D; Weiss S; Cafarella M; Snyder JJ; Israni AK; Kasiske BL Am J Transplant; 2023 Feb; 23(2 Suppl 1):S178-S263. PubMed ID: 37132348 [TBL] [Abstract][Full Text] [Related]
23. Liver transplantation in the United States, 1999-2008. Thuluvath PJ; Guidinger MK; Fung JJ; Johnson LB; Rayhill SC; Pelletier SJ Am J Transplant; 2010 Apr; 10(4 Pt 2):1003-19. PubMed ID: 20420649 [TBL] [Abstract][Full Text] [Related]
24. Does living donation have advantages over deceased donation in liver transplantation? Kaido T; Uemoto S J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant. Lai Q; Sapisochin G; Gorgen A; Vitale A; Halazun KJ; Iesari S; Schaefer B; Bhangui P; Mennini G; Wong TCL; Uemoto S; Lin CC; Mittler J; Ikegami T; Yang Z; Frigo AC; Zheng SS; Soejima Y; Hoppe-Lotichius M; Chen CL; Kaido T; Lo CM; Rossi M; Soin AS; Finkenstedt A; Emond JC; Cillo U; Lerut JP JAMA Surg; 2021 Sep; 156(9):e213112. PubMed ID: 34259797 [TBL] [Abstract][Full Text] [Related]
26. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. Trotter JF; Osgood MJ JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206 [TBL] [Abstract][Full Text] [Related]
27. OPTN/SRTR 2021 Annual Data Report: Intestine. Horslen SP; Wood NL; Cafarella M; Schnellinger EM Am J Transplant; 2023 Feb; 23(2 Suppl 1):S264-S299. PubMed ID: 37132347 [TBL] [Abstract][Full Text] [Related]
28. Living donor liver transplantation for hepatocellular carcinoma. Lee SG; Moon DB Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020 [TBL] [Abstract][Full Text] [Related]
29. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score. Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556 [TBL] [Abstract][Full Text] [Related]
30. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption. Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266 [TBL] [Abstract][Full Text] [Related]
31. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score. Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903 [TBL] [Abstract][Full Text] [Related]
32. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Di Sandro S; Slim AO; Giacomoni A; Lauterio A; Mangoni I; Aseni P; Pirotta V; Aldumour A; Mihaylov P; De Carlis L Transplant Proc; 2009 May; 41(4):1283-5. PubMed ID: 19460539 [TBL] [Abstract][Full Text] [Related]
33. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses. Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614 [TBL] [Abstract][Full Text] [Related]
34. Development of the allocation system for deceased donor liver transplantation. Coombes JM; Trotter JF Clin Med Res; 2005 May; 3(2):87-92. PubMed ID: 16012126 [TBL] [Abstract][Full Text] [Related]
35. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil. Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144 [TBL] [Abstract][Full Text] [Related]
36. Improved Survival Following Living Donor Liver Transplantation for Pediatric Acute Liver Failure: Analysis of 20 Years of US National Registry Data. Firl DJ; Sasaki K; McVey J; Hupertz V; Radhakrishnan K; Fujiki M; Eghtesad B; Miller CM; Quintini C; Hashimoto K Liver Transpl; 2019 Aug; 25(8):1241-1250. PubMed ID: 31119826 [TBL] [Abstract][Full Text] [Related]
37. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Renz JF; Kin C; Kinkhabwala M; Jan D; Varadarajan R; Goldstein M; Brown R; Emond JC Ann Surg; 2005 Oct; 242(4):556-63; discussion 563-5. PubMed ID: 16192816 [TBL] [Abstract][Full Text] [Related]
38. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Thuluvath PJ; Yoo HY Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301 [TBL] [Abstract][Full Text] [Related]
39. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry. Taniguchi M Clin Transpl; 2012; ():41-65. PubMed ID: 23721009 [TBL] [Abstract][Full Text] [Related]
40. Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center. Lai JC; Pichardo EM; Emond JC; Brown RS Am J Transplant; 2009 Mar; 9(3):586-91. PubMed ID: 19191773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]